Dr. Dirk Jaeger is the managing director and the head of the Department of Medical Oncology at the National Center for Tumor Diseases of the University Clinic of Heidelberg, where he focuses on translating innovative immunotherapies into early clinical trials. Dr. Jaeger is a member of CRI’s Clinical Leadership Committee.